Jefferies Group LLC Anavex Life Sciences Corp. Transaction History
Jefferies Group LLC
- $10.2 Billion
- Q3 2022
A detailed history of Jefferies Group LLC transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Jefferies Group LLC holds 50,000 shares of AVXL stock, worth $425,500. This represents 0.01% of its overall portfolio holdings.
Number of Shares
50,000
Previous 3,403
1369.29%
Holding current value
$425,500
Previous $34,000
1417.65%
% of portfolio
0.01%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding AVXL
# of Institutions
166Shares Held
26.6MCall Options Held
518KPut Options Held
838K-
Black Rock Inc. New York, NY6.39MShares$54.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.74MShares$40.3 Million0.0% of portfolio
-
State Street Corp Boston, MA3.07MShares$26.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.88MShares$16 Million0.0% of portfolio
-
Nwam LLC Mercer Island, WA913KShares$7.77 Million0.62% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $663M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...